Lista de obras -

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

scientific article published on 01 September 2020

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.

artículo científico publicado en 2018

Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?

artículo científico publicado en 2015

Immature uterine teratoma associated with uterine inversion

artículo científico publicado en 2014

Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status

scientific article published on 20 May 2019

LKB1 mutations in NSCLC are associated with KEAP1/NRF2-dependent radiotherapy resistance targetable by glutaminase inhibition

artículo científico publicado en 2020

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC

artículo científico publicado en 2018

Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)

artículo científico publicado en 2018

Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?

artículo científico publicado en 2017

PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer

scientific article published on 16 February 2019

Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma

artículo científico publicado en 2017

Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC.

artículo científico publicado en 2017

Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.

artículo científico publicado en 2015

TRACERx: Tracking tumor evolution to impact the course of lung cancer.

artículo científico publicado en 2017

The Cancer Genome Atlas findings in head and neck cancer: a renewed hope.

artículo científico publicado en 2014

The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics

artículo científico publicado en 2021

Lista de obras de

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.

Definitive chemoradiotherapy for advanced cervical cancer: should it be different in the elderly?

Immature uterine teratoma associated with uterine inversion

Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status

LKB1 mutations in NSCLC are associated with KEAP1/NRF2-dependent radiotherapy resistance targetable by glutaminase inhibition

Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC

Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC)

Management of Para-aortic Lymph Node Disease in Patients With Cervical Cancer: What Is the Best Approach?

PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer

Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma

Sequential liquid biopsies reveal dynamic alterations of EGFR driver mutations and indicate EGFR amplification as a new mechanism of resistance to osimertinib in NSCLC.

Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.

TRACERx: Tracking tumor evolution to impact the course of lung cancer.

The Cancer Genome Atlas findings in head and neck cancer: a renewed hope.

The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics